Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Prostate cancer in Denmark. Incidence, morbidity and mortality

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Carcinoma of the prostate. Classification

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Carcinoma of the prostate. Early diagnosis--screening

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Carcinoma of the prostate. Prognostic factors

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Community-based football in men with prostate cancer: 1-year follow-up on a pragmatic, multicentre randomised controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Palliative Prostate Artery Embolization for Prostate Cancer: A Case Series

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Predictive value of AZGP1 following radical prostatectomy for prostate cancer: a cohort study and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Active Surveillance Versus Radical Prostatectomy in Favorable-risk Localized Prostate Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Prostate cancer incidence and mortality rates in Denmark are reviewed for a 50-year period from 1943 to 1992. The prostate cancer incidence rate nearly tripled and prostate cancer mortality rate increased during this period. Until recently in Denmark the routine management of prostate cancer has been by deferred hormonal therapy. Morbidity and mortality associated with prostate cancer are analysed in a group of 1459 patients aged 55-74 years, who were diagnosed as having clinically localized prostate cancer in the 5-year period 1983 to 1987. In this group of patients prostate cancer is demonstrated to cause significant morbidity. Furthermore, the patients suffered significant excess mortality and loss of life expectancy.
Original languageEnglish
Book seriesScandinavian Journal of Urology and Nephrology. Supplement
Volume203
Pages (from-to)29-33
Number of pages5
ISSN0300-8886
Publication statusPublished - 1999

    Research areas

  • Aged, Denmark, Humans, Incidence, Male, Middle Aged, Prostatic Neoplasms

ID: 36730531